Recurrent SARS-CoV-2 Serology Testing and Pandemic Anxiety: A Study of Pediatric Healthcare Workers

Natasha Li, Sarah R. Martin, Theodore W. Heyming, Chloe Knudsen-Robbins, Terence Sanger and Zeev N. Kain
Additional contact information
Natasha Li: Children’s Health of Orange County, Orange, CA 92868, USA
Sarah R. Martin: Children’s Health of Orange County, Orange, CA 92868, USA
Theodore W. Heyming: Children’s Health of Orange County, Orange, CA 92868, USA
Chloe Knudsen-Robbins: School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA
Terence Sanger: Children’s Health of Orange County, Orange, CA 92868, USA
Zeev N. Kain: Children’s Health of Orange County, Orange, CA 92868, USA

IJERPH, 2022, vol. 19, issue 15, 1-9

Abstract: Background: Limited access to SARS-CoV-2 testing has been identified as a potential source of anxiety among healthcare workers (HCWs), but the impact of repeated testing on pandemic-related anxiety in pediatric HCWs has not been examined. We sought to understand the impact of repeated SARS-CoV-2 antibody testing on pediatric HCWs’ COVID-19 anxiety. Methods: This longitudinal cohort study was conducted between April and July 2020. Participants, 362 pediatric HCWs, underwent rapid SARS-CoV-2 antibody testing either every 96 h or weekly and were asked to rate their COVID-19 anxiety on a visual analog scale. Changes in self-reported anxiety from the study baseline were calculated for each testing day response. Bivariate analyses, repeated measures, and logistic regression analyses were performed to examine demographics associated with changes in anxiety. Results: Baseline COVID-19 anxiety was significantly higher in HCWs with less than 10 years of experience ( Z = −2.63, p = 0.009), in females compared to males ( Z = −3.66 p < 0.001), and in nurses compared to other HCWs ( F (3,302) = 6.04, p = 0.003). After excluding participants who received a positive test result, repeated measures analyses indicated that anxiety decreased over time ( F (5,835) = 3.14, p = 0.008). Of the HCWs who reported decreased anxiety, 57 (29.8%) had a clinically meaningful decrease (≥30%) and Emergency Department (ED) HCWs were 1.97 times more likely to report a clinically meaningful decrease in anxiety ( X 2 (1) = 5.05, p = 0.025). Conclusions: The results suggest that repeated SARS-CoV-2 antibody serology testing is associated with decreased COVID-19 anxiety in HCWs. Routine screening for the disease may be a helpful strategy in attenuating pandemic-related anxiety in pediatric HCWs.

Keywords: anxiety; COVID-19; pediatrics; antibody testing (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/15/9562/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/15/9562/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:15:p:9562-:d:879638

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().